In addition, Dyrk1B inhibition by RO5454948 sensitized the pancreatic cancer cell lines Panc1 and SU86.86 to gemcitabine, as well as the colorectal cancer cell line SW620 to cisplatin [59]. This evidence concerns the gene DYRK1B and colorectal cancer.